Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « MeshFr.i » - entrée « Indice de gravité médicale »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Indicateurs d'état de santé < Indice de gravité médicale < Indice de masse corporelle  Facettes :

List of bibliographic references indexed by Indice de gravité médicale

Number of relevant bibliographic references: 223.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000011 (2020) Binqing Fu ; Xiaoling Xu ; Haiming WeiWhy tocilizumab could be an effective treatment for severe COVID-19?
000653 (2019) Lianne Kearsley-Fleet [Royaume-Uni] ; Sunil Sampath [Royaume-Uni] ; Liza J. Mccann [Royaume-Uni] ; Eileen Baildam [Royaume-Uni] ; Michael W. Beresford [Royaume-Uni] ; Rebecca Davies [Royaume-Uni] ; Diederik De Cock [Royaume-Uni] ; Helen E. Foster [Royaume-Uni] ; Taunton R. Southwood [Royaume-Uni] ; Wendy Thomson [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni]Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom.
000677 (2019) Nienke M. Ter Haar ; E. H. Pieter Van Dijkhuizen ; Joost F. Swart ; Annet Van Royen-Kerkhof ; Ayman El Idrissi ; Arjen P. Leek ; Wilco De Jager ; Mark C. H. De Groot ; Saskia Haitjema ; Dirk Holzinger ; Dirk Foell ; Jorg Van Loosdregt ; Nico M. Wulffraat ; Sytze De Roock ; Sebastiaan J. VastertTreatment to Target Using Recombinant Interleukin‐1 Receptor Antagonist as First‐Line Monotherapy in New‐Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five‐Year Follow‐Up Study
000870 (2019) Ching-Tsai Lin [Taïwan] ; Wen-Nan Huang [Taïwan] ; Chia-Wei Hsieh [Taïwan] ; Yi-Ming Chen [Taïwan] ; Der-Yuan Chen [Taïwan] ; Tsu-Yi Hsieh [Taïwan] ; Yi-Hsing Chen [Taïwan]Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis - A three-year study in Taiwan.
000902 (2019) Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Yasuyo Abe [Japon] ; Toshihiko Hidaka [Japon] ; Naoyuki Hirakata [Japon] ; Kiyoshi Aoyagi [Japon] ; Yukitaka Ueki [Japon]Retention of tocilizumab with and without methotrexate during maintenance therapy for rheumatoid arthritis: the ACTRA-RI cohort study.
000930 (2019) Durga Prasanna Misra [Inde] ; Anupam Wakhlu [Inde] ; Vikas Agarwal [Inde] ; Debashish Danda [Inde]Recent advances in the management of Takayasu arteritis.
000A92 (2019) Ana F. Águeda [Portugal] ; Sara Monti [Italie] ; Raashid Ahmed Luqmani [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Maria Cid [Espagne] ; Bhaskar Dasgupta [Royaume-Uni] ; Christian Dejaco [Italie, Autriche] ; Alfred Mahr [France] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Wolfgang Schmidt [Allemagne] ; Bernhard Hellmich [Allemagne]Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis
000B13 (2019) Vivian P. Bykerk [États-Unis] ; Andrew J K. Östör [Australie] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Michael T. Nurmohamed [Pays-Bas] ; Yves Luder [Suisse] ; Paris N M. Sidiropoulos [États-Unis] ; Jenny Devenport [États-Unis] ; Jean Sibilia [France]Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.
000B34 (2019) Sibel Balci [Turquie] ; Rabia Miray Kisla Ekinci [Turquie] ; Aysun Karabay Bayazit [Turquie] ; Engin Melek [Turquie] ; Dilek Dogruel [Turquie] ; Derya Ufuk Altintas [Turquie] ; Mustafa Yilmaz [Turquie]Juvenile systemic lupus erythematosus: a single-center experience from southern Turkey.
000B65 (2019) Maxime Ma Verhoeven [Pays-Bas] ; Marjolein Jh De Hair [Pays-Bas] ; Janneke Tekstra [Pays-Bas] ; Johannes Wj Bijlsma [Pays-Bas] ; Jacob M. Van Laar [Pays-Bas] ; Attila Pethoe-Schramm [Suisse] ; Michelle Ea Borm [Pays-Bas] ; Evert-Jan Ter Borg [Pays-Bas] ; Suzanne P. Linn-Rasker [Pays-Bas] ; Xavier M. Teitsma [Pays-Bas] ; Floris Pjg Lafeber [Pays-Bas] ; Johannes Wg Jacobs [Pays-Bas] ; Paco Mj Welsing [Pays-Bas]Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials.
000C94 (2019) Francisco Airton Castro Rocha [Brésil] ; Joaquim Ivo Vasques Dantas Landim [Brésil] ; Marcela Gondim Aguiar [Brésil] ; João Pedro Emrich Accioly [Brésil] ; Carolina Noronha Lechiu [Brésil] ; Luiza Helena Acácio Costa [Brésil] ; Carlos Nobre Rabelo Júnior [Brésil] ; Leila Nascimento Da Rocha [Brésil] ; Hermano Alexandre Lima Rocha [Brésil]Evaluation of disease activity in a low-income juvenile idiopathic arthritis cohort.
000E06 (2019) Natalia Genere [États-Unis] ; Marius N. Stan [États-Unis]Current and Emerging Treatment Strategies for Graves' Orbitopathy.
000E36 (2019) Stephanie Finzel [Allemagne] ; Sebastian Kraus [Allemagne] ; Camille Pinto Figueiredo [Allemagne] ; Adrian Regensburger [Allemagne] ; Roland Kocijan [Allemagne] ; Juergen Rech [Allemagne] ; Georg Schett [Allemagne]Comparison of the effects of tocilizumab monotherapy and adalimumab in combination with methotrexate on bone erosion repair in rheumatoid arthritis.
000E92 (2019) Sezgin Sahin [Turquie] ; Duhan Hopurcuoglu [Turquie] ; Sule Bektas [Turquie] ; Ezgi Belhan [Turquie] ; Amra Adrovic [Turquie] ; Kenan Barut [Turquie] ; Nur Canpolat [Turquie] ; Salim Caliskan [Turquie] ; Lale Sever [Turquie] ; Ozgur Kasapcopur [Turquie]Childhood-onset Takayasu arteritis: A 15-year experience from a tertiary referral center.
001031 (2019) April Zhang [États-Unis] ; James Nocton [États-Unis] ; Yvonne Chiu [États-Unis]A Case of Pansclerotic Morphea Treated With Tocilizumab.
001103 (2018) Alan Kivitz [Canada] ; Ewa Olech [Canada] ; Michael A. Borofsky [Canada] ; Beatriz Zazueta [Canada] ; Federico Navarro-Sarabia [Canada] ; Sebastião C. Radominski [Canada] ; Joan T. Merrill [Canada] ; César Pacheco-Tena [Canada] ; Jinglan Pei [Canada] ; Clare Nasmyth-Miller [Canada] ; Janet E. Pope [Canada]Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis.
001141 (2018) Yuko Kaneko [Japon] ; Masaru Kato [Japon] ; Yoshiya Tanaka [Japon] ; Masayuki Inoo [Japon] ; Hitomi Kobayashi-Haraoka [Japon] ; Koichi Amano [Japon] ; Masayuki Miyata [Japon] ; Yohko Murakawa [Japon] ; Hidekara Yasuoka [Japon] ; Shintaro Hirata [Japon] ; Eiichi Tanaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Hisashi Yamanaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Tsutomu Takeuchi [Japon]Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study).
001187 (2018) Carlos A. Canas [Colombie] ; Fabio Bonilla-Abadia [Colombie] ; Katherine Vallejo [Colombie] ; Hector M. Rengifo [Colombie] ; Marco A. Gallon [Colombie] ; Gabriel J. Tobon [Colombie]Successful Treatment for Severe Thyroid-associated Ophthalmopathy with Tocilizumab.
001194 (2018) Giuseppina Stifano [États-Unis] ; Thierry Sornasse [États-Unis] ; Lisa M. Rice [États-Unis] ; Leo Na [États-Unis] ; Haiyin Chen-Harris [États-Unis] ; Dinesh Khanna [États-Unis] ; Angelika Jahreis [États-Unis] ; Yuqing Zhang [États-Unis] ; Jeff Siegel [États-Unis] ; Robert Lafyatis [États-Unis]Skin gene expression is prognostic for the trajectory of skin disease in patients with diffuse cutaneous systemic sclerosis
001198 (2018) Lianne Kearsley-Fleet [Royaume-Uni] ; Michael W. Beresford [Royaume-Uni] ; Rebecca Davies [Royaume-Uni] ; Diederik De Cock [Royaume-Uni] ; Eileen Baildam [Royaume-Uni] ; Helen E. Foster [Royaume-Uni] ; Taunton R. Southwood [Royaume-Uni] ; Wendy Thomson [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni]Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra
001205 (2018) Jean-Hugues Salmon ; Jeanne-Marie Perotin ; Jacques Morel [France] ; Moustapha Dramé ; Alain Cantagrel [France] ; Liana Euller Ziegler ; Philippe Ravaud [France] ; Jean Sibilia ; Isabelle Pane [France] ; Xavier Mariette ; Jacques-Eric Gottenberg [France]Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Indice de gravité médicale" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Indice de gravité médicale" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Indice de gravité médicale
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021